Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Steger

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Transplantation Proceedings|March 27, 2001
Cellular basis of long-term rat liver allograft acceptance: role of donor and recipient leukocyte persistence in rat liver graftsU Steger, I Klein, C Otto, et al.
Transplantation Proceedings|September 2, 1998
Selective immunosuppression with FK 506, anti-IL-2R, and anti-ICAM-1 monoclonal antibodies: contrasting effects after liver and small bowel transplantation in ratsC Otto, M Gasser, H J Gassel, et al.
Transplantation|April 13, 2000
Tolerance of rat liver allografts induced by short-term selective immunosuppression combining monoclonal antibodies directed against CD25 and CD54 with subtherapeutic cyclosporineH J Gassel, C Otto, A M Gassel, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Analysis of cellular events in hepatic allografts: donor progenitors induce intragraft chimerismH J Gassel, C Otto, I Klein, et al.
Transplantation|July 17, 2001
Persistence of stable intragraft cell chimerism in rat liver allografts after drug-induced toleranceH J Gassel, C Otto, I Klein, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 26, 2007
Identification of gene markers for the prediction of allograft rejection or permanent acceptanceB Sawitzki, A Bushell, U Steger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2014
Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)G Folprecht, T Gruenberger, W Bechstein, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Transplantation Proceedings|March 27, 2001
Cellular basis of long-term rat liver allograft acceptance: role of donor and recipient leukocyte persistence in rat liver graftsU Steger, I Klein, C Otto, et al.
Transplantation Proceedings|September 2, 1998
Selective immunosuppression with FK 506, anti-IL-2R, and anti-ICAM-1 monoclonal antibodies: contrasting effects after liver and small bowel transplantation in ratsC Otto, M Gasser, H J Gassel, et al.
Transplantation|April 13, 2000
Tolerance of rat liver allografts induced by short-term selective immunosuppression combining monoclonal antibodies directed against CD25 and CD54 with subtherapeutic cyclosporineH J Gassel, C Otto, A M Gassel, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Analysis of cellular events in hepatic allografts: donor progenitors induce intragraft chimerismH J Gassel, C Otto, I Klein, et al.
Transplantation|July 17, 2001
Persistence of stable intragraft cell chimerism in rat liver allografts after drug-induced toleranceH J Gassel, C Otto, I Klein, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 26, 2007
Identification of gene markers for the prediction of allograft rejection or permanent acceptanceB Sawitzki, A Bushell, U Steger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2014
Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)G Folprecht, T Gruenberger, W Bechstein, et al.
Pageof 2